Rafael Holdings, Inc. (RFL): Shareholders' Equity
$98.37M
As of 2025-07-31
$80.80M
As of 2026-04-30
+0.4%
3-year compound annual growth
-5.5%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-07-31 | $98.37M | +14.0% | 2025-10-29, Balance as of period end |
| 2024-07-31 | $86.26M | -10.7% | 2025-10-29, Balance as of period end |
| 2023-07-31 | $96.63M | -0.6% | 2024-12-20, Balance as of period end |
| 2022-07-31 | $97.21M | -28.9% | 2023-10-30, Balance as of period end |
| 2021-07-31 | $136.70M | +4.7% | 2022-10-31, Balance as of period end |
| 2020-07-31 | $130.53M | +4.6% | 2021-10-18, Balance as of period end |
| 2019-07-31 | $124.76M | +8.0% | 2020-10-29, Balance as of period end |
| 2018-07-31 | $115.56M | +86.2% | 2019-10-04, Balance as of period end |
| 2017-07-31 | $62.08M | +27.2% | 2018-10-15, Balance as of period end |
| 2016-07-31 | $48.81M | n/a | 2018-10-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $98.37M | +14.0% |
| Rallybio Corp (RLYB) | 2025-12-31 | $57.96M | -6.0% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $82.39M | +3.5% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $3.46M | -14.2% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $2.84M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $15.76M | +84.5% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | -$2.09M | n/m |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $29.71M | +92.4% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $24.60M | +29.5% |
Compare RFL, RLYB, STTK, SXTP side by side · Screen every company in Pharmaceutical Preparations ↗